A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White ...
Editor’s Comment, Nelda Murri, PharmD: The public health consequences of national drug shortages are sobering ... following the announcement of a new drug shortage. One author has estimated ...
Widespread shortages of cancer drugs, including widely used carboplatin, are forcing doctors to make difficult decisions ...
A new report from the Senate Committee on Homeland Security and Governmental Affairs said drug shortages, which increased nearly 30 percent from 2021 to 2022, pose health and national security ...
There were 301 active national drug shortages through ... to a recent report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security and Governmental Affairs.
HOW MANY DRUG SHORTAGES ARE THERE? There were 301 active national ... to a recent report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security and ...
The drug shortage is due to manufacturing issues, delays in production, suppliers mishandling materials and the ...
Through the first three months of the quarter, there were 301 active national drug shortages ... report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security ...
A substantial number of physicians suspect there may be market manipulation behind at least some of the shortages. A report to the ... of an unavailable drug. The risk of errors is increased ...
A recent report from the U.S. Senate Committee on Homeland Security and Governmental Affairs identified 295 active drug shortages ... suppliers could pose a national security risk.
The drug is used to treat inflammatory conditions like arthritis and psoriasis, along with certain types of cancer. Shortages ...
including nearly 50 new shortages that accumulated in the first three months of the year. The last time active drug shortages – including both newly reported and ongoing – were this high was ...
